553
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Classification of anti-HIV compounds using counterpropagation artificial neural networks and decision trees

, , , &
Pages 639-660 | Received 09 Feb 2011, Accepted 03 Jun 2011, Published online: 14 Oct 2011
 

Abstract

The main aim of the present work was to collect and categorize anti-HIV molecules in order to identify general structure–activity relationships. In this respect, a total of 5580 drugs and drug-like molecules was collected from 256 different articles published between 1992 and 2010. An algorithm called genetic algorithm–pattern search counterpropagation artificial neural networks (GPS-CPANN) was proposed for the classification of compounds. In addition, the CART (classification and regression trees) method was used for construction of decision trees and finding the best molecular descriptors. The results revealed that the developed CPANN models and decision tree can correctly classify the molecules according to their inhibition mechanisms and activities. Some general parameters such as molecular weight, average molecular weight, number of hydrogen atoms and number of hydroxyl groups were found to be important for describing the inhibition behaviour of anti-HIV agents. The developed classifier models in this work can be used to screen large libraries of compounds to identify those likely to display activity as anti-HIV agents.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.